Don't know about the $5, but from what I've read, the pipeline, partner and their quarterly reports, this looks like a little train that could move up. From my limited experience, most small bio cap company's are good with the research but very poor when it comes to the business, marketing and sale side. Do like what I have seen with this company. So I'll just hang around a while and see what happens. GLTA